NEUPROGRAMMIERUNG VON KÖRPERZELLEN

Patent europeic · EP3878949 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3878949
Numer da la dumonda
EP21162420
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-04-2008
Publitgà
15-09-2021
Concedì
04-06-2025
La protecziun finescha il pli tard
06-04-2028
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
C12N 5/074 (2010.01)
Prioritad
US 922121 P 07.04.2007
US 959341 P 12.07.2007
US 3606508 P 12.03.2008
Derivà da
EP08742630
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 16-04-2026

    Midada

    Published in Swissreg on 16.04.2026

  2. 04-06-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.06.2025

Partidas

Possessur

Whitehead Institute for Biomedical Research

455 Main Street, Cambridge, MA 02142, US

Inventur

JAENISCH, Rudolph

Brookline, MA 02146, US

HANNA, Jacob

Boston, MA 02118, US

WERNIG, Marius

Cambridge, MA 021139, US

LENGNER, Christopher, J.

Wellesley, MA 12481, US

MEISSNER, Alexander

Cambridge, MA 02142, US

BRAMBRINK, Oliver, Tobias

Cambridge, MA 02138, US

WELSTEAD, G., Grant

Cambridge, MA 02139, US

FOREMAN, Ruth

Somerville, MA 02145, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.